Osteoboost Health, Inc.

Based in the US, Bone Health Technologies Inc. specializes in innovative solutions for bone health, particularly through their flagship product, Osteoboost, designed to address osteopenia in postmenopausal women. Bone Health Technologies, Inc. was founded in 2018 and is headquartered in Redwood City, US.

The company focuses on developing therapeutic solutions to improve bone health. The founders include Daniel Burnett, Marcie Hamilton, and Shane Mangrum, while Laura Yecies serves as the CEO. The company has successfully completed 7 deals and raised a total of USD 5. 00 mn in funding, with the latest round attracting investors such as Berkeley Catalyst Fund, Esplanade Ventures, and Terumo.

Osteoboost is a pioneering company offering FDA-cleared vibration therapy designed specifically for postmenopausal women experiencing osteopenia. The core product, Osteoboost, is a wearable device that utilizes precision vibration therapy to stimulate bone-building cells, thereby improving bone density and reducing bone loss. This innovative therapy is based on scientific research initially developed for NASA to combat bone loss in space. The device is intended for daily use, fitting seamlessly into users' routines, such as during walking or cooking.

Osteoboost primarily serves a client base of healthcare providers and patients in the United States and select international markets, focusing on individuals seeking non-drug interventions to enhance bone health and prevent osteoporosis. Osteoboost generates revenue through direct-to-consumer sales of its flagship product alongside partnerships with healthcare providers. Customers purchase the Osteoboost device through various channels, which may include online platforms and medical facilities. The revenue model emphasizes the accessibility of the Osteoboost therapy for individuals diagnosed with osteopenia, positioning the product as a critical intervention for maintaining bone health.

The transactional structure involves one-time purchases for the device, supplemented by potential ongoing sales of ancillary products or subscription-based services for continued support and usage guidance. Bone Health Technologies, Inc. is looking to expand its product line and enhance its market presence. The company has plans for upcoming product launches, specifically targeting additional therapeutic devices designed for broader applications in bone health.

With the recent funding round raising USD 5. 00 mn, the company intends to allocate resources towards market expansion, particularly in Europe and Asia by the end of 2024. Additionally, Bone Health Technologies aims to further develop partnerships with healthcare providers to broaden the reach of Osteoboost and improve accessibility for patients.